II
ARA

Ibex Investors’s American Renal Associates Holdings, Inc ARA Stock Holding History

Ibex Investors’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-14,034
Closed -$265K – 265
2018
Q1 		$265K Buy
+14,034
New +$277K 0.22% 175

Other funds holding ARA

CP
Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WIC
Whitegate Investment Counselors Concord, New Hampshire $315M AUM 10.6% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ibex Investors's ARA Position: Q2 2018 in Review

Ibex Investors sold out of American Renal Associates Holdings, Inc (ARA) in Q2 2018, closing a stake of 14,034 shares — an estimated $265K sold.

Ibex Investors first reported a position in ARA in Q1 2018 and held it in 1 quarter. The position peaked at $265K in Q1 2018. 80 funds tracked by Wall St. Rank hold ARA as of Q2 2018.

  • Ibex Investors reported no remaining American Renal Associates Holdings, Inc position as of Q2 2018 after selling out during the quarter.
  • Ibex Investors sold 14,034 American Renal Associates Holdings, Inc shares in Q2 2018, an estimated $265K.
  • Ibex Investors first reported a position in American Renal Associates Holdings, Inc in Q1 2018 and held it in 1 quarter.
  • Ibex Investors's American Renal Associates Holdings, Inc position peaked at $265K in Q1 2018.
  • 80 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q2 2018.

Based on Ibex Investors's 13F filing for Q2 2018, filed 14 Aug 2018.